Ganjapreneur.com

a word from our sponsors:

The largest-ever survey conducted on cannabidiol (CBD) users found 80 percent of respondents reporting the cannabinoid “very effective” or “extremely effective” in treating their respective conditions, with 42 percent reporting they actually stopped using traditional prescription and over-the-counter medicines and replacing them with CBD-based products.

The study was conducted by HelloMD, one of the nation’s largest online communities of medical cannabis patients, and Brightfield Group, a marketing and research firm specializing in cannabis industry data and analysis.

Among the cannabis users surveyed, 75 percent used CBD products, with half reporting using whole plant-derived CBD and 20 percent using hemp-derived CBD products. Of those, 80 percent said they used CBD products at least once a week, and 41 percent indicated they used the products daily. Interestingly, 58 percent of CBD-only users are women, according to the study.

Women gravitating more toward CBD

Dr. Perry Solomon, chief medical officer for HelloMD, said he was “a little surprised” that women represented the majority of CBD users in the study, noting that a previous study conducted by the company found 36 percent of women used cannabis generally, and another found 44 percent of women consumed cannabis.

“I can only guess as to why,” he said in an interview with Ganjapreneur. “One of the reasons may be that women aren’t looking for the psychoactive effect of THC combined in their product and are looking for a purely anxiety-reducing type of medicine. … I think they are looking for a medicine that doesn’t cause a psychoactive effect – that’s the only logical conclusion I can draw.”

Bethany Gomez, director of research for Brightfield Group, said she believes part of the reason women used CBD-only products more than their male counterparts is that they tend to do more research and, while laypersons still don’t know much about CBD, women often look deeper into the information when trying to treat their condition.

“Women are doing more research and more aware of the products,” she said in an interview. “As well as CBD may be beneficial for them especially in conditions more interceded with women.”

Cannabidiol (CBD) has grown dramatically in popularity in recent years and can be sourced either from industrial hemp plants or medicinal cannabis plants, pictured above. *Photo Credit: Cannabis Pictures*

CBD replacing pharmaceuticals

The researchers found 65 percent of respondents used CBD to treat anxiety, with insomnia or sleep problems being the second most reported condition treated with CBD products (60 percent.) Another 54 percent said they used CBD to treat joint pain and inflammation and about 45 percent used the cannabinoid to treat symptoms of depression. About 35 percent of individuals experiencing muscle tension or strain reported using CBD, and just about the same number of respondents indicated using CBD to treat migraines or tension headaches. Thirty-two percent of respondents said they used CBD to treat severe or chronic pain, while 31 percent were arthritis sufferers who said it helped treat the condition. Thirty-one percent of hemp-derived CBD users said CBD worked to treat their nausea, compared to 26 percent whose CBD was derived from non-hemp sources.

Thirty-five percent of CBD users also used prescription pain killers, such as Vicodin, and slighty less (34 percent) used prescription anti-anxiety medication, such as Xanex; another 20 percent indicated using prescription sleep medication like Ambien. Sixty-five percent regularly used over-the-counter pain relievers, while about 40 percent used over-the-counter ointments or topicals to relieve pain, such as BenGay. About 44 percent also used herbal or natural remedies to ease the symptoms of their condition.

Of those, 42 percent have replaced their over-the-counter or prescription medication with CBD, while 37 percent reported using traditional medications in conjunction with cannabis products, with 20 percent saying they alternate between the two. Just 1 percent of respondents said they used other medicines instead of cannabis. Slightly more hemp-derived CBD users (43 percent) used cannabis in lieu of traditional medications than those who use whole plant-derived CBD products (40 percent.) Sixty-six percent of respondents indicated that, overall, CBD therapies were either “much more effective” or “more effective” than over-the-counter medicines.

Solomon said he was surprised by the number of people who stopped using traditional medication in favor of CBD.

“If people are able to cut down on opioids … and even anti-inflammatories … it’s a huge win for anyone that wants to try and get off traditional medication or finds that it doesn’t work,” he explained. “That being said I think people need to be very cognizant about what and where they are purchasing just in terms of the quality of the CBD.”

Survey respondents indicated that vape pens were their delivery method of choice, which Gomez said was in line with national industry trends.

“People are increasingly looking to vape as opposed to flower or as opposed to other product types because it’s a healthier method of consumption,” she said. “Particularly for CBD, there’s more products available and when it comes to CBD people want to go toward more packaged products. … It’s fast-acting and it’s reliable.”

Solomon explained that while there may be some consumer concerns about components of vape pens – such as the coils and nickel used in production – the availability and the ease of using the device makes them a popular option.

“It’s just what’s easier for the patient, and how soon do they want it to work,” he said, adding that CBD tincture doesn’t have any of those byproducts but takes more time for the body to process.

According to the research, CW Hemp’s Charlotte’s Web was far and away the most popular brand. Plus CBD Oil, Mary’s Medicinals, TetraLabs, and Bluebird Botanicals rounded out the top five – although it should be noted that the majority of the 2,400 HelloMD members (86 percent) hailed from California. One percent each resided in New York and Arizona, and about 1 percent lived in Canada and Europe. The remainder was from 41 other U.S. states.

End

Jon Gowa: Robotics in the Cannabis Industry

8/03/2017

a word from our sponsors:

Jon Gowa is the founder and CEO of Bloom Automation, a company that is designing and creating robots in Colorado to assist the cannabis industry.

In this episode of the Ganjapreneur.com podcast, our host TG Branfalt and Jon discuss Bloom Automation’s participation in the Boulder Canopy startup incubator, the various robot designs they have tested and found most effective, what role robotics may play in the future of the cannabis industry, and more!

You can listen to the interview via the media player below or keep scrolling down to read a full transcript of this week’s Ganjapreneur.com podcast episode.

Listen to the podcast:

Read the transcript:

TG Branfalt: Hey, there. I’m your host, TG Branfalt and you’re listening to the Ganjapreneur.com podcast where we try to bring you the actionable information to normalize cannabis through the stories of ganjapreneurs, activists and industry stakeholders. Today, I’m joined by Jon Gowa. He’s the CEO and founder of Bloom Automations. Jon, you guys make robots.

Jon Gowa: We do indeed. We make robots to help the cannabis industry.

TG Branfalt: That’s the crux of what we’re going to get into a little bit later, robots, how do they work — but before we get into that, I want to know about you. Tell me about what you did before entering the cannabis space.

Jon Gowa: Great. I’ve been an engineer for about seven years now. I initially started out actually in agricultural robotics at a firm called Harvest Automation and there, we made robots that moved potted plants such as rose bushes.

TG Branfalt: How did you decide to enter the cannabis space and did you use your previous experience to build this tech?

Jon Gowa: Yeah. Definitely, I would say I was inspired by my previous experience and honestly, one day, I was watching television. I believe it was a CNBC program about the cannabis industry and saw a particular task, this task of trimming and thought that might be something perfect for robots.

TG Branfalt: Again, we’re going to talk about the robots but I want to talk about a couple other things first. I want to talk about the accelerator program that you guys are involved in, the Canopy Boulder program.

Jon Gowa: Absolutely.

TG Branfalt: What was your application and pitch process like to get involved with that program? How did you discover it?

Jon Gowa: Okay. Canopy Boulder, we discovered it through the ArcView program and we were at one of their conferences, Canopy Boulder was set up with impressive booth and a list of companies that were at this investor forum. We got to know them. We got to know Micah. He said, “Why don’t you apply?” Later, last fall, I was in Boulder and actually met again at Canopy, learned a little bit more about the program, about their alumni and found it a fascinating opportunity.

TG Branfalt: What was the application and the pitch process like for you guys? Was it the Shark Tank experience? Were you in front of a bunch of people and …

Jon Gowa: Although we have had that experience on stage at ArcView, the Canopy Boulder application was a little more friendly. You mainly filled out a lot of forms online and wrote about exactly why you’re in the industry, where your goal is, and really pitching from there.

TG Branfalt: Why did you choose an accelerator program over other ways of finding investments such as finding direct investors or venture capitalists?

Jon Gowa: Great question. I think for us, it was more about getting really immersed in the industry. Although laws are changed in Massachusetts where I’m from, things are really developed out here in Colorado. To actually get to know industry professionals, get to know hopefully our potential clients and what their needs are, it seems like a good idea to come out here.

TG Branfalt: The Canopy Boulder experience and the culture, what’s that like working so closely with other companies who are designing their own tech or doing something entirely different and working with a lot of people who have very broad knowledge base?

Jon Gowa: Exactly. I would say it’s absolutely fascinating. We get to work, exactly like you say, with companies that have such varied skills. In this environment, it’s not so much competitive as it is collaborative. When I needed help working on the website, Henry from Cannabis Big Data knows all about website, all about analytics and was able to get me up and running in honestly 30 minutes, something that would have taken us weeks and more. Yeah, they have that kind of collaboration and everyone working towards the same goal, granted they’re on the same company … on different companies but we’re like working towards the same goal in the same industry.

TG Branfalt: I had an interview with the CEO of the San Diego Canopy and he appeared on the podcast. He said that one of the goals for their program, and they specifically bring in a lot of tech projects is they’re not looking for something that reinvented the wheel, so to speak. They’re more interested in picks and axes rather than gold so they don’t have any companies that touch the plant, that sort of thing. In Boulder, do you have the same experience in that program where it’s more picks and axes as opposed to the gold, if you will?

Jon Gowa: We do. We do have that same experience and the same criteria for it to be an ancillary company. I think that’s interesting and it’s also … because we’re all ancillary companies, we’re tied in that sense. Our clients are all similar so it’s really … it’s kind of a good thing for our company.

TG Branfalt: Tell me about your company. Tell me about Bloom Automation. You have robots. What do these robots do? Who’s using them?

Jon Gowa: Great. We have robots and it’s mainly aimed at the task of trimming which is after you harvest the cannabis, you have the flowers and then you have the sugar leaves and the fan leaves or the water leaves. Although the leaves are still valuable, you want to remove those and separate them. There’s numerous ways of doing it. Typically, it’s hand-trimmed or there’s some large machines that trim it but these machines are a little bit more coarse, so to speak. We’re looking at robots that could use cameras and they actually look at the cannabis and understand each different plant, each different branch and are able to cater that when it goes to actually trim and operate on that branch.

TG Branfalt: These aren’t like humanoid robots, right, that are holding scissors and doing this? These are more production style robots?

Jon Gowa: I would say it’s somewhat of a mix, so our next generation robot, it does wield a pair of shears, they look quite like a regular scissors and it uses an articulated arm that enables it to be more dexterous. Meanwhile, our initial prototype which is online and functioning right now like you said, looks more like a production piece of equipment, even kind of like a 3D printer. The robots are changing in form.

TG Branfalt: Already?

Jon Gowa: Already to kind of make sure we’re precise, as precise as a human and as we learn different capabilities and restrictions of a particular robot or system, we’re adapting to this.

TG Branfalt: I read that the automation increases security. I was wondering if you could just tell our listeners how automation does increase security and why.

Jon Gowa: Automation can certainly increase security by … It’s a more controlled environment. Certainly, if you have conveyor belts, you have your product going from one conveyor perhaps through a robot, it’s all controlled. It’s very unlikely you’re going to lose any product particularly with all the cameras, automated cameras. For that reason, you have a good control of your product throughout the entire process whether it’s trimming or going through packaging. Automation can certainly help.

TG Branfalt: You had mentioned earlier that your tech is already sort of evolving. Give me some sort of specifics about what has happened since the early test phase to now.

Jon Gowa: Exactly. Early on, although we’ve always used cameras, we had numerous different sensors like touch sensors and other sensors but now, we rely completely on cameras. What’s changed is in the beginning, the robot was a lot more cumbersome, so to speak. Sometimes, it ate an entire flower without really knowing it. Now, we’ve refined that algorithm much, much further. It knows exactly where each leaf is. It no longer has false positives or false negatives and it’s certainly more precise and more efficient. In fact, it’s almost 10 times faster than when we started.

TG Branfalt: Tell me how much product it can go through and how accurate is it.

Jon Gowa: Okay. We’re aiming for the production model to go through at least a quarter pound dry equivalent per hour. That would represent the equivalent of perhaps one to two hand trimmers. The accuracy is quite good. We’re at about 80% right now but we really want to hit that 95% threshold which is, it starts looking exactly like a hand-trimmed product. It’s very precise.

TG Branfalt: How far are you away do you think from hitting that 95% goal?

Jon Gowa: We have beta testing to begin at some cultivation sites across the country, about six of these sites. From there, that’s where we really start to gather data so we’ll see how are these actually performing in real life, what is the accuracy that the cultivators are reporting because it is something of subjective matter and from there, we’re going to make incremental improvements until we hope we get to that 95%.

TG Branfalt: What do you mean by it’s subjective? What does that mean when you’re dealing with data? Data is not really subjective.

Jon Gowa: Right. For accuracy, some would say some cultivators prefer a closer cut where perhaps you’re trimming the sugar leaves very down low, of course, getting all the crow’s feet but other trimmers, especially when the product is wet, might consider it okay to leave some sugar leaf because it still has product on it, active product. I think it depends on cultivator to cultivator. That’s actually something we want to program into the robots. This is one of the levers they can pull but we want to make sure when they pull that lever, they’re getting a desired outcome.

TG Branfalt: The system is adaptable.

Jon Gowa: That’s correct. There will be some tunability whether they want, like I said, a closer trim or perhaps a looser trim and that can be for numerous reasons from speed to, of course, just how they like their product.

TG Branfalt: That’s really cool stuff. We got to take our first break. I’m TG Branfalt. This is Ganjapreneur.com podcast.

This episode of the Ganjapreneur.com podcast is made possible by Name.com, a global provider of domain name, web hosting and e-mail services. Every successful cannabis business needs an online presence and every successful online presence begins with a domain. From your website to your e-mail address, a good domain is easy for your customers to remember. It looks nice on a business card or billboard and it reflects the true identity of the project it represents.

It’s important to reserve your domain early on when you are starting your business as you may find that the dotcom address for your preferred brand or concept has already been taken. If somebody has already purchased the ideal dotcom for your business, they might be willing to sell it but if they aren’t, you may have to get creative with one of the new alternate domain extensions such as .co, .club, .shop, or even .farm.

Reserve your domain name today at name.com/ganjapreneur. If you are a domain name investor or a venture capital firm interested in acquiring or advertising premium cannabis domains, go to the Ganjapreneur domain market to browse a wide variety of names including strains.com, cannabismedia.com, mj.com and countless others. Discover branding opportunities for your next startup and learn about listing your premium domain names for sale at Ganjapreneur.com/domains, sponsored by Name.com.

TG Branfalt: Hey, welcome back. It’s the Ganjapreneur.com podcast. I’m your host, TG Branfalt here with Jon Gowa, CEO and founder of Bloom Automation. Before the break, we’re talking a bit about how the robot works but there’s going to be … You’re definitely going to get some voices who are saying that one of the benefits of legalization is job creation. A February report from New Frontier estimated the cannabis space to create 250,000 jobs by 2020 while manufacturing, government and utility jobs decrease by 814,000, 47,000 and 383,000 respectively. What is your response to people who might see your robots as a threat to job creation in the cannabis space?

Jon Gowa: Yes. The robots and automation in general really works to increase efficiencies. Often, what occurs there is as opposed to eliminating jobs,
you’re actually creating more jobs such as everything … The robot needs an operator. These current robots, for example, don’t feed themselves. Branches need to be fed in. Then, of course, there’s robot technicians, robot programmers and a number of jobs that are actually on-site jobs that will be created. What we like to look at is the efficiency improvements that these robots can provide employers and enable them to employ even more people whether it’s down the line or actually helping the robots.

TG Branfalt: Well, and tech companies need a variety of talent as well. What are you guys going to be looking for as you expand in terms of talent?

Jon Gowa: Certainly. Everything from, of course, programmers who are experienced in robotics and specifically vision to then we would need robot technicians across the country because robots, they break down like any piece of capital equipment or any piece of equipment really. We will be wanting to train particularly people that are familiar with other equipment in the cannabis industry whether it’s they’re trained on lighting equipment, dehumidification equipment. We’ll be looking for those same people and hopefully train them how to work on the robots so that we have technicians capable all across the country and when a cultivator needs them, they can go out and service the robots and of course, individuals that would operate the robots and then, we are planning on United States manufacturing so we’ll need an army of assembly technicians as well.

TG Branfalt: So far, have you been able to find qualified people to do the jobs that you’re looking for and if so, what sectors are they coming from?

Jon Gowa: Great question. For example, we’ve been looking for contractors that are familiar with cameras and how cameras integrate with robots and typically, that’s in automation field. We found contractors everywhere from Denver to San Diego to Tampa, Florida who all not only have an interest in the field but have a strong interest. They see it as a growth industry and have said that there’s request from other people, from cultivators themselves. We’ve had very good response honestly from vendors and industry professionals outside of the cannabis industry.

TG Branfalt: What other functions might robots be able to perform in the cannabis supply chain?

Jon Gowa: We’ve already seen some equipment whether you would call it an automation equipment or robotics, that help package cannabis, help package flower. One of the things I know that’s being looked at is packaging concentrate products. No pun intended but it’s really a sticky process and … yeah.

TG Branfalt: I love puns.

Jon Gowa: It’s tough to really … The process is called gramming and I think it’s pretty tough to do manually.

TG Branfalt: That’s something that people might be looking towards robots for or are they already being utilized?

Jon Gowa: They’re not being utilized but they are looking towards that, just one example, to help packaging, help packaging efficiency, consistency so that every time you look at the product, it’s consistent to what you expect.

TG Branfalt: When you approach a cultivator and you tell them, “Hey, I’ve got these trimming robots,” what’s their reaction?

Jon Gowa: Generally, their reaction is fairly positive. I think trimming is often seen as one of not the most desirable jobs in the industry. What we hear from cultivators is they love their great trimmers but all their great trimmers want to do is move up to that next level where they’re no longer trimming, so it’s difficult for them to find good trimmers and if they could instead operate robots that would really equate to this quality, they would love to do so.

TG Branfalt: How much training would somebody who’s trimming by hand now need to operate one of these robots?

Jon Gowa: Certainly, I think a large population of the trimmers right now are of the age that they’re quite familiar with technology and the robot’s operated through a touch panel control. It’s fairly intuitive. It’s a small combination of mechanical, just how you load the branches and then simply following kind of on-screen instructions. I think they would get sort of used to the errors that might happen with the robot and learn how to adjust those pretty quickly. It’s very similar to how humans work with robots in the automotive industry. It’s pretty collaborative.

TG Branfalt: You don’t need to have like an engineering degree or something to operate these?

Jon Gowa: No. Absolutely not. We really would count on those hand trimmers and other employees to assume these roles.

TG Branfalt: We got to take our last break. When we come back, we’re going to talk about something you and I both know a little bit about and that’s cannabis on the East Coast. Before we do that, we’ll take a break. This is the Ganjapreneur.com podcast. I’m TG Branfalt.

At Ganjapreneur, we have heard from dozens of cannabis business owners who have encountered the issue of canna-bias which is when a mainstream business, whether a landlord, bank or some other provider of vital business services refuses to do business with them simply because of their association with cannabis. We have even heard stories of businesses being unable to provide health and life insurance for their employees because the insurance providers were too afraid to work with them. We believe that this fear is totally unreasonable and that cannabis business owners deserve access to the same services and resources that other businesses are afforded, that they should be able to hire consultation to help them follow the letter of the law in their business endeavors and that they should be able to provide employee benefits without needing to compromise on the quality of coverage they can offer.

This is why we created the Ganjapreneur.com business service directory, a resource for cannabis professionals to find and connect with service providers who are cannabis friendly and who are actively seeking cannabis industry clients. If you are considering hiring a business consultant, lawyer, accountant, web designer or any other ancillary service for your business, go to ganjapreneur.com/businesses to browse hundreds of agencies, firms and organizations who support cannabis legalization and who want to help you grow your business.

With so many options to choose from in each service category, you will be able to browse company profiles and do research on multiple companies in advance so you can find a provider who is the best fit for your particular need. Our business service directory is intended to be a useful and well maintained resource which is why we individually vet each listing that is submitted. If you are a business service provider who wants to work with cannabis clients, you may be a good fit for our service directory. Go to ganjapreneur.com/businesses to create your profile and start connecting with cannabis entrepreneurs today.

TG Branfalt: Welcome back to the Ganjapreneur.com podcast. I’m your host, TG Branfalt with Jon Gowa, CEO and founder of Bloom Automation. You had mentioned earlier you’re from Massachusetts. I lived in New York for years and years. I spent tons of time in Massachusetts and I was stoked and maybe a little surprised when they passed cannabis legalization last November. It was a huge domino that toppled in New England because of Boston and the power politics that are played, I’m certainly sure you know, in Massachusetts. Were you confident going into that vote? What were your feelings as a native going into the November election?

Jon Gowa: No. I was hopeful but I wouldn’t say I was completely confident. I knew in the earlier polls, it was somewhat split but at least we had passed medicinal and then decriminalization. I was hopeful we would follow suit and certainly pleased with the outcome there.

TG Branfalt: Do you have the same sort of feeling that I do that it was kind of the first domino? I mean that and Maine, that I mean it was a simultaneous thing but to me, New England or I’m sorry, Massachusetts is sort of the bigger of the two fish if we’re frying them. Do you kind of get that sense as well that … I mean now, we got Vermont who just, the legislature passed, strange legalization bill. Delaware is working on it. I hear Rhode Island but do you think that it took Massachusetts to kind of get that ball rolling?

Jon Gowa: Personally, I do think it did take Massachusetts to really get everything rolling. I think just as other states have looked to Colorado including Massachusetts, I think other New England states will continue to watch Massachusetts as the legalization plays out.

TG Branfalt: Well, and there’s been some setbacks. The legislature delayed implementation from January to July 2018. Several municipalities have enacted either moratoriums or total bans. They have approved the funds for the program which is a start. How confident are activists and canna-business owners in Massachusetts that the state will meet that July 2018 deadline? What are your concerns about the law if any or its implementation?

Jon Gowa: I certainly hope that the law is implemented. As you said, it was supposed to be in January. I certainly hope in July, I think the voters have voted. The time has come but the cities that haven’t, for the cities that haven’t or that have pushed back, I think they’re losing out and I’m sure eventually, they’ll turn, just like some cities here in Colorado have. Then, yeah, I’m not 100% confident on the actual meeting the timeline. It’s really, I mean … yeah.

TG Branfalt: Finally, what advice would you have for entrepreneurs, specifically those interested in entering the tech sector?

Jon Gowa: Great. I think there’s ideas. There’s thousands of ideas but really, I would say building your team, whether it’s just you and a partner or you and two partners, building a team where you really complement each other and then really looking at your opportunities, so if you have an idea and you have a prototype, then maybe you start looking for some investment but otherwise, these incubators are really … It’s a really good opportunity to get to know the entire industry, get to know venture capital. Myself, I’m not an MBA but this is kind of like a mini-MBA. I would certainly advise that to any entrepreneur whether you’re an engineer or not, or a business professional or not.

TG Branfalt: Finally, can you tell us where we can find more about your product?

Jon Gowa: Absolutely. On our website at bloomautomation.com and of course, at our Twitter, @bloomrobots. Both is a great opportunity to learn more.

TG Branfalt: Awesome, man. Well, thank you for taking the time out to be on the show. It’s really cool tech that you guys are rolling out and I really can’t wait to see how it exactly develops. That’s, I think, going to be a really fascinating thing to keep my eye on.

Jon Gowa: Yes. Thank you really much, Tim. I love the show and I’ll be anxious to hear more from you.

TG Branfalt: Thanks so much. You can find more episodes of the Ganjapreneur.com podcast in the podcast section of Ganjapreneur.com and in the Apple iTunes store. On the Ganjapreneur.com website, you’ll find the latest cannabis news and cannabis jobs updated daily along with transcripts of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. This episode was engineered by Jeremy Sebastiano. I’ve been your host, TG Branfalt.

End

A commercial jet takes off from the Las Vegas International Airport in Las Vegas, Nevada.

Broad Proposal Would Ban Cannabis Advertisements in Las Vegas Airport

8/03/2017

a word from our sponsors:

During a public hearing by the Clark County Commission, which encompasses Las Vegas’ McCarren International Airport, commissioners proposed an ordinance that would ban cannabis advertisements and make cannabis possession illegal on all airport-owned properties, according to a report from Aviation Pros. However, if approved as-is, cannabis advertisements could also be banned from vehicles carrying passengers to and from the airport, such as taxis.

Nevada Director of Aviation Rosemary Vassiliadis said the ordinance was an effort to keep the airport in federal compliance but not to control “the transient vehicles that come through the airport.” She said her staff would work to clear up the wording; however several commissioners expressed interest in keeping the language of the proposal broad.

“I don’t want it anywhere,” said Commissioner Marilyn Kirkpatrick, the board’s most outspoken opponent of legalized cannabis, in the report.

Commissioner Larry Brown said he would like to see the board “go to the limit” in reigning in industry advertising.

“Ban everything related to recreational and medical marijuana,” he said. “Once (the industries) have a track record, we can adjust.”

Vassiliadis told the commissioners that the advertising ordinance “has to be realistic.”

The commission ultimately made no decision on the proposal, tabling it for 30 days while they seek input from the state Taxicab Authority, Green Ribbon Advisory Panel, and other interested parties.

End

Senator Ron Wyden speaks at the Smithsonian Folklife Festival at Oregon State University.

Oregon Sen. Asks AG Sessions to Release DOJ Crime and Public Safety Task Force Report

8/03/2017

a word from our sponsors:

Last week, advocates and cannabis industry operators were expecting an explosive report from the Department of Justice Task Force on Crime and Public Safety – but the report was never made public. Instead, Attorney General Jeff Sessions released a statement outlining the work of the task force explaining that he had been given a report, and would review the task force’s recommendations.

On Tuesday, Sen. Ron Wyden, whose home state of Oregon has legalized the use and sale of cannabis, sent a letter to Sessions pressing him to make those recommendations public.

“The American people have a right to know the basis for enforcement policy changes made by the Department of Justice,” he wrote. “… These DOJ decisions could have dramatic and wide ranging consequences for Americans’ daily lives.”

In the letter, Wyden expressed concern “about the secrecy shrouding the recommendations provided to [Sessions] by the task force’s marijuana subcommittee. He notes an April memo in which Sessions singles out cannabis policy, worrying that, combined with Sessions’ past statements on legalized cannabis, the DOJ could use the report to “justify federal actions that undermine states’ rights to set their own marijuana laws.”

“The citizens of Oregon voted to legalize medical and recreational marijuana, and it is not the role of the Attorney General to unilaterally undermine the will of Oregon voters on the basis of uncorroborated claims and furtive recommendations made by a task force shielded from public input and scrutiny,” Wyden says in the letter.

The senator concludes by asking Sessions why he has not released the recommendations. Wyden also asks Sessions to provide him with copies of the report if he does not plan on releasing it publicly.

End

Plastic bags of kettle corn sit in a pile during an event at the Del Mar Fairgrounds near San Diego.

San Diego Cannabis-Themed Festival Cancelled by Fairgrounds

8/03/2017

a word from our sponsors:

The Goodlife Festival, a cannabis-theme event set for late September, has been canceled by the Del Mar Fairgrounds despite the organizer saying he would rewrite the contract to hold the festival without cannabis after the District Agricultural Association board canceled the event’s contract, the San Diego Tribune reports.

Lawrence Bame, CEO of the festival, indicated he was “willing to agree to anything” but the board refused to negotiate and told him “don’t come back.”

“Nobody wants to put anything in writing, especially the board, especially for a smoking policy,” he said in the report. “I just got a phone call saying ‘You can’t go back to the board this year.’”

Tim Fennell, CEO of the fairgrounds, declined to address Bame’s allegation that Fennell refused to put anything indicating the deal was off in writing.

“Lawrence Bame is welcome to bring this issue before the board later this year,” he wrote in a statement to the Tribune. “The 22nd DAA is waiting for the Department of Food and Agriculture to provide rules and regulations in order to proceed with these type of events.”

Cannabis would not have been sold at the event, even under the stipulations of the original contract, but attendees would have been allowed to bring their own cannabis and smoke it in designated sections. Bame had lobbied for the event since 2010 and called the decision by the board “schizophrenic” because the DAA board allows other events that draw cannabis consumers – just less overtly than the Goodlife Festival.

Adult-use cannabis legalization is set to take effect in California starting January 1.

End

Minnesota Judge Orders Smuggling Case Involving Ex-Vireo Employees to Continue

8/03/2017

a word from our sponsors:

A Minnesota judge has denied the motion to throw out charges against two former Vireo Health officers accused of illegally transporting $500,000 in cannabis products from Minnesota to New York while trying to meet a January 2016 deadline under New York’s medical cannabis program, according to a report from the Journal News.

Dr. Laura Bultman, former chief medical officer for Vireo, and Ronald Owens, the former security officer, are accused of using the company’s armored car to transport the products – in violation of federal and state laws.

Judge Kathleen Mottl ruled that the alleged smuggling scheme is not protected under Minnesota state law or federal corporate laws. Mottl concluded that the duo acted alone and that no current Vireo Health officials are implicated in the case. Health officials in New York are conducting an independent investigation.

Andrew Mangini, a spokesman for Vireo Health, said Mottl’s decision was “a reminder that neither Vireo Health nor any of its affiliates are a party” to the actions of the accused former employees.

“This ruling follows closely on the recent news that the licenses for both Vireo Health of New York and Minnesota Medical Solutions were renewed by state regulators,” he said in the report. “As always, we will continue to remain laser-focused on serving patients suffering from serious conditions like chronic pain, cancer, ALS and HIV/AIDS.”

Both Bultman and Owens have pleaded not guilty.

End

An indoor cannabis crop in a licensed cannabis cultivation site in Washington state.

Alaska Cannabis Tax Revenues Reach New High

8/02/2017

a word from our sponsors:

Tax revenues derived from Alaska’s legal cannabis industry nearly doubled from May to June, from $272,100 to $512,200 – the most in a single month since sales began in late October, Alaska Dispatch News reports. Officials from the state Department of Revenue are anticipating the trend will continue for July.

“This is really incredible,” Kelly Mazzei, excise tax supervisor for the tax division, told ADN reporter Laurel Andrews. “We knew it would happen; we just didn’t know when.”

In addition to the sales taxes, 40 growers and 15 cultivators paid the state in June and Alaska netted $1,748,500 from legal cannabis sales during the fiscal year, which ended on June 30. The state had projected $2 million after downgrading their projections twice following slower-than-expected sales in January and February.

In June, 547 pounds of flower and 313 pounds of trim were sold by cultivators in the state. Flower is taxed $50-per-ounce and trim is taxed $15-per-ounce.

“We also anticipate much larger quantities being sold or transferred [in July] by outdoor cultivators as those crops are harvested,” Mazzei said in the report.

Under state law, half of the tax revenues are earmarked for the state’s general fund, while the remaining is used for programs to reduce repeat criminal offenders.

End

A NFL quarterback looks down field to make a pass.

NFL Offers Partnership with Union on MMJ

8/02/2017

a word from our sponsors:

NFL officials have offered to work with the NFL Players Association on the potential of cannabis as a pain management tool for players, according to a Washington Post report. In a letter, league officials outlined areas for potential research including pain management for acute and chronic conditions.

The letter comes one week after a study was published in the medical journal JAMA which found Chronic Traumatic Encephalopathy, a neurodegenerative brain disease, in the brains of 110 of 111 deceased former players. Several studies have purported that cannabis has neuroprotective qualities; the most recent was conducted by researchers at Israel’s Tel Aviv University’s Adelson Center for the Biology of Addictive Diseases as the Sackler Faculty of Medicine published in 2013.

“We look forward to working with the Players Association on all issues involving the health and safety of our players,” said Joe Lockhart, the NFL’s executive vice president of communications, in the report.

The union has been independently investigating alternative pain management treatments, convening a pain management committee last year. Additionally, NFLPA Executive Director DeMaurice Smith has called on the league to relax its cannabis policies, urging league officials “to not simply assume recreation is the reason [cannabis] is being used” by players. In May, Smith said in an interview with ESPN Outside the Lines that the union intends to present a proposal to the league “that has probably a more therapeutic approach” to players who test positive for cannabis.

The NFLPA has not publicly responded to the league request to collaborate on the potential of medical cannabis use in the league.

End

New York Adds Five Companies to MMJ Roster

8/02/2017

a word from our sponsors:

New York has doubled the number of available medical cannabis licenses from five to 10, despite objections from current operators claiming that the demand doesn’t call for an expansion. However, according to a New York Post report, the number of registered patients has increased 70 percent since March – from 10,744 to 25,736 – following the addition of chronic pain to the qualifying condition list in December. Patients with the condition were allowed to access the program on March 21.

State Health Commissioner Dr. Howard Zucker said adding the additional licenses “will make it easier for patients across the state to obtain medical marijuana.”

“The New York State Department of Health is committed to growing the state’s Medical Marijuana Program responsibly,” he said in the report, adding that the increased competition will reduce the cost of medical cannabis products in the state and increase variety of available products.

The new producers include Fiorello Pharmaceuticals, Citiva, Terradiol, PalliaTech NY, and Valley Agriceuticals.

Fiorello plans to dispense in Midtown Manhattan, Long Island, and upstate New York; Citiva is eyeing locations in Brooklyn, Staten Island, and upstate New York; Terradiol and PalliaTech plan to dispense in Queens; and Valley Agriceuticals is planning on setting up shop in Brooklyn.

If all 10 licensed operators in the state open their four allowed dispensaries, there would be 40 retail locations total statewide.

End

A long, dusty road in sunny South Dakota.

Typo Could Derail Legalization Effort in South Dakota

8/02/2017

a word from our sponsors:

One sentence in the 11-page ballot initiative to legalize cannabis for adult use in South Dakota could doom the entire proposal, according to a CBS News report. The section legalizing paraphernalia addresses the laws of “the state or subdivision” (cities or counties); however, the section legalizing cannabis use doesn’t include “the state or,” just the laws of the subdivision.

The conclusion – that the measure would legalize paraphernalia state-wide but not adult cannabis use – was interpreted by the nonpartisan Legislative Research Council.

Melissa Mentele, director for advocacy group New Approach South Dakota, who are circulating the petitions, indicated the error could be fixed by the Legislature or the courts and she is “not concerned about it at all.”

“It’s just a typo,” she said in the report. “It’s one person’s perception of grammar versus another’s.”

Jason Hancock, Legislative Research Council director, disagrees. He said that the supporters could submit an amended proposal but that would void all existing signatures collected to put the issue to voters in 2018. Advocates must collect 14,000 signatures by November in order to be successful. If they have to submit a new proposal, it could take up to 90 days for the attorney general’s office to publish an explanation, which would make gathering the signatures impossible.

Jesse Kelley, a Marijuana Policy Project attorney who worked on the proposal, indicated that this is “not a new issue” for cannabis ballot measures, noting that in other states advocates have emerged from court victorious.

End

New Jersey Sen. Cory Booker Introduces Federal Cannabis Legalization Proposal

8/01/2017

by Graham Abbott

a word from our sponsors:

https://www.facebook.com/corybooker/videos/10157111094132228/?hc_ref=ARRZw2ydVDlHqKr3P3O06zPsBZWa8lKXZuIWVMS0-BCzV2_0LS_9ITJartmub6QZkQM

Sen. Cory Booker, a New Jersey Democrat and former mayor of Newark, introduced a proposal today that would legalize cannabis at the federal level and penalize states whose marijuana laws disproportionately target low-income and minority communities, according to a Politico report.

The Marijuana Justice Act, similar to other legalization bills that have been introduced at the federal level, would remove cannabis from the Controlled Substances Act.

The bill, however, goes much further than that. If passed, the proposal would take a number of steps towards righting the wrong of cannabis prohibition: states who choose to maintain the status quo would see some federal funds withheld, the proposal would expunge all federal cannabis arrests and grant prisoners currently imprisoned for a cannabis-related offense the right to a sentencing hearing, and would also establish a new Community Reinvestment Fund that would seek to help communities who have been disproportionately harmed by the enforcement of federal cannabis laws.

“You see these marijuana arrests happening so much in our country, targeting certain communities — poor communities, minority communities — targeting people with an illness,” Booker said during a Facebook Live announcement of his legislation.

The chances of Booker’s bill being passed this session are slim at best: the majority of the Republican-held Congress still opposes legalization and the Trump Administration has even threatened a crackdown enforcement of federal cannabis laws on state-legal programs. Nonetheless, the Marijuana Justice Act is the most comprehensive and cannabis-friendly legalization proposal ever to be introduced by a federal lawmaker and is a sign of the recent and massive change in the federal landscape for cannabis policy.

Eight states and the District of Columbia have legalized adult-use cannabis. In his announcement, Booker said that, “They’re actually seeing positive things coming out of that experience.”

Notably, Sen. Booker’s home state of New Jersey is not among those states and he has not officially endorsed legalization in his own state — though there are lawmakers poised to propose legalization at the state level following current Gov. Chris Christie’s departure from office.

End

Photo from outside the Ohio State Capitol Building in Columbus, Ohio.

Ohio Legislative Committee Passes MMJ Rules

8/01/2017

a word from our sponsors:

The Ohio legislature’s Joint Committee on Agency Rule review has approved the rules for the state’s medical cannabis program one month before the statutory deadline, according to a Cleveland.com report. Under the rules, patients will have to pay a $50 registration fee annually and will be able to possess a 90-day supply, defined as up to 8 ounces of flower or products containing a comparable amount of THC.

Ohio is the first state to quantify limits this way, which equates to a patient purchasing 70 days’ worth of flower and 20 days’ worth of vape products or edibles. Patients can designate up to two caregivers to make purchases on their behalf and caregivers, who will pay a $25 fee per application, can serve up to two patients except in some situations set forth by the state Pharmacy Board such as hospice care.

The state Commerce Department will license up to 40 processors who will pay a $10,000 application fee and, if approved for a license, will pay another $90,000 and then $100,000 annually to renew. Sixty dispensaries will be approved, with applicants paying $5,000 and $70,000 bi-annually if approved.

Physicians in the state must take a two-hour continuing education course and register with the state in order to make medical cannabis recommendations to patients. They are also required to explain the benefits and risks associated with use.

Lawmakers passed the medical cannabis bill in May 2016, but it’s still expected to be more than a year before the state’s infrastructure is ready for patients.

End

An official NBA Spalding basketball sitting on some grass on a sunny day.

NBA Commissioner Defends Cannabis Ban, Cites State Law Discrepancies

8/01/2017

a word from our sponsors:

In an interview with the Players’ Tribune, NBA commissioner Adam Silver indicated he doesn’t “see the need for any changes” in the league’s cannabis policy “right now” because of the patchwork of cannabis laws state-to-state throughout the U.S.

“…As you know, our players are constantly traveling, and it might be a bit of a trap to say we’re going to legalize it in these states, but no, it’s illegal in other states,” Silver said in the interview. “And then players get in a position where they’re traveling with marijuana, and we’re obviously getting into trouble.”

The NBA is home to eight teams in states with legalized adult cannabis use, including the Washington Wizards from Washington, D.C.; four teams hail from California, one from Colorado, one from Massachusetts, and one from Oregon.

While the league still suspends players for cannabis use, the ban is limited to five games. Earlier this year, Steve Kerr, the coach who last season led the Golden State Warriors to a championship — their second in three years — admitted to trying medical cannabis to ease chronic back pain; however, he said “it didn’t work” for him.

Kerr added that he believes “it’s only a matter of time” before medical cannabis is an accepted therapy in all of the major sports leagues because, eventually, “the education will overwhelm the perception.”

End

A security camera covered in mud and dirt, mounted on an overgrown outdoor wall.

Top Five Security & Surveillance Infractions for Cannabis Companies

8/01/2017

by Azam Khan

a word from our sponsors:

Some of the most costly violations for marijuana businesses are related to inadequate security and surveillance systems in licensed marijuana operations. When violations or incidents occur with inventory, employees, or activities within the licensed premises, the first standard procedure is for regulatory authorities to review the surveillance system. Any issues related to the security and surveillance system are often found during reviews of other non-related infractions.

After more than 600 cannabis compliance inspections, here are the top infractions for security and surveillance observed via the Adherence SCORE App for cannabis compliance in 2017.

The cameras do not have a clear, unobstructed view of all activity without sight blockage.
All records applicable to the surveillance system are not maintained on the licensed premises.
The licensee does not have a current list of authorized employees and service personnel who have access to the surveillance system.
The licensee does not maintain a diagram of the surveillance camera locations, direction of coverage, and assigned camera numbers.
The video surveillance system does not have an “active” notification system for interruptions and failures (cannot be email or web-based alerts)

Smart steps to ensure security compliance

All cameras in the facility should have a clear, unobstructed views of all activity. A good regulatory test for license owners or operators is to have an employee walk through the facility with an empty box. If during the walk through the employee and/or box are not visible on the surveillance system, then a violation can occur. As security and surveillance infractions are considered “public safety” issues, violations can be expensive and require administrative hearings with regulatory authorities. For owners, it’s best to avoid all types of violations and administrative actions to ensure the monetary value of the license itself is not diminished.

Another common infraction for security and surveillance is inadequate service and maintenance records maintained on-site. As the surveillance system is considered “evidentiary” in nature, all records must be maintained to ensure compliance. A surveillance log should include details on each occurrence of access to the DVR system, including maintenance and routine inspections. Surveillance systems should be contained in a securely locked room or cabinet and properly annotated on the diagrams of the licensed premises.

Often, the digital recording system of the DVR can fail without proper notice to the owner or operations manager. Cameras will appear “active” on the DVR monitoring system, but the hard drive behind the scenes may not be recording activity. Unless an alarming mechanism for these type of failures is “active,” i.e. a phone call or text message, it could be insufficient in terms of regulatory compliance. Passive alarms (email or web-based warning) are not considered compliant in most states or jurisdictions.

Keep any area where cannabis inventory may be prepped, processed, or transported under strict security surveillance. *Photo Credit: Sarah Climaco*

As inventory is considered ‘chain-of-custody’ in most states, a secure, fully functional security and surveillance system needs to be in place, as well as routinely reviewed and inspected. Any areas of the facility that prep, process, weigh, package, or initiate transport or receipt of product should be under video surveillance. This will ensure any and all operational issues (missing inventory, theft, workplace injury, etc.) are recorded and can be reviewed as required by authorities. Failure to properly record operational infractions can lead to additional fines, criminal or civil penalties, probation and/or license revocation.

Best practices for marijuana businesses are to ensure:

Your security and surveillance provider has an in-depth service level agreement (SLA).
The facility diagram includes a map of cameras, with camera numbers and line of sight.
Time and date stamps are accurate on each DVR system and all cameras are operational.
The DVR system is locked and secured with a detailed access and maintenance log history.
A list of approved stakeholders who can access the DVR system is available at the facility.

Note: This article was co-authored by Steven Owens. Steven Owens is the CEO of Adherence Compliance. He has more than 15 years of software and executive management experience working for leading technology firms such as Oracle and Alcatel Lucent.

End

Poll: Utah Citizens Overwhelmingly Back Medical Cannabis Legalization

8/01/2017

a word from our sponsors:

A supermajority of Utah citizens – 78 percent – support the medical cannabis ballot initiative being circulated by advocates in the state, according to a Dan Jones & Associates poll commissioned by the Salt Lake Tribune and the Hinckley Institute of Politics. The campaign is headed by the Utah Patients Coalition who need to collect 11,143 valid signatures by registered voters by April 15 in order to put the issue to voters in November 2018.

The poll, which surveyed 605 Utah voters, found the issue has the support of 97 percent of Democrats and 65 percent of Republicans in the state. Advocates can count Jon Huntsman Sr. among those supporters – the philanthropist and father of former Utah governor Jon Huntsman last month threw his support behind the measure.

“If medical marijuana was known by another name, it would have been utilized as a pain medication many years ago,” he told the Salt Lake Tribune. “From national research and understanding, the side effects of medical marijuana are considerably less than virtually all opioids and therefore less destructive to the body.”

The supermajority is nearly 25 percentage points higher than a January poll commissioned by Tribune-Hinckley, which found 54 percent supported medical cannabis.

Despite the public support, state Rep. Brad Daw believes that the initiative in its current form is too broad and that once voters see what’s in the initiative “they will pull back,” although he admitted that the poll results don’t surprise him because he has seen similar levels of support among his constituents, according to a Tribune report.

In Utah, patients with severe epilepsy are currently able to acquire hemp extract registration cards that allow them to import whole-plant CBD oil from states with medical cannabis programs. According to the report, from July 2014 to October 2016 just 166 such cards were issued.

This past week, the coalition held 10 public meetings on the issue as required by law to advance a ballot initiative. The measure would allow individuals suffering from cancer, multiple sclerosis, autism, chronic pain, post-traumatic stress disorder, and Alzheimer’s disease to access the program.

End

A brightly colored sunset off the coast of Hawaii.

First Lab Licensed to Test Medical Cannabis in Hawaii

8/01/2017

a word from our sponsors:

Hawaii’s patients are one step closer to finally gaining access to medical cannabis dispensaries more than two years after the passage of the state’s Medical Marijuana Dispensary program law as the Department of Health has licensed Steep Hill Hawaii to test medical cannabis products, Maui Now reports.

Keith Ridley, chief of the Health Department’s Office of Health Care Assurance and overseer of the medical cannabis dispensary program, called the license issuance “a major step forward” in allowing dispensaries to test their products so they can be sold to qualified patients.

“We realize that registered patients and caregivers and some of the licensed dispensaries have been waiting for a laboratory to become operational to test medical cannabis prior to consumption and sale,” he said in the report.

Steep Hill will be the first to test products, as required under the law, for cannabinoid profile, heavy metals, solvents, pesticides, moisture content, intestinal bacteria, microbial contaminants, pathogens, and dangerous molds.

Chris Whelen, head of the Department of Health’s State Laboratories Division, indicated the agency is currently working with two other independent labs to help them gain state certification to test cannabis before it heads to dispensaries for sale.

“Certification follows a rigorous scientific process that requires meticulous attention to detail and constant refining to ensure product and patient safety,” he said, noting that the interested labs “are continuing to submit or resubmit their validation studies for certification.”

Under Hawaii state law, labs are prohibited from handling cannabis products until they are certified by the state.

End

Ecommerce and online shopping/delivery orders are the way of the future.

Cannabis Ecommerce Made Easy With WeedHero

8/01/2017

by Featured Announcement

a word from our sponsors:

With North American cannabis sales growing at an unprecedented rate — 2016 alone saw a 30 percent increase across the continent to a total of $6.7 billion in sales throughout the U.S. and Canada — medical cannabis dispensaries and adult-use retailers have seen a remarkable increase in traffic, both in person and online.

WeedHero — a family-run business based out of Portland, Oregon — is a revolutionary ecommerce system designed to smooth interactions between retailers and customers, allowing customers to browse and purchase their favorite products in the most convenient of ways.

“We believe software should not be complex. We wanted to build a product that works smarter, better and allows dispensary owners to do things their way to bring positive improvements to their sales,” said Constantine Yaremtso, co-founder of WeedHero.

WeedHero is an online ordering and delivery software suite that will turn your cannabis dispensary’s website into a powerful ecommerce shop. The full-featured marketing software is designed to enhance a dispensary’s online potentials and comes with search engine-friendly menus that can include pictures and prices of your products, the ability for customers to choose between pick-up or delivery options, automatic information gathering on clients’ orders, recording and categorizing your customers’ favorite products, options for reordering and loyalty programs, and more.

WeedHero normally provides free installation and a 15-day risk-free trial period — for Ganjapreneur readers, however, that trial offer has been extended to an entire month, so don’t wait! Visit the WeedHero website to see a demo of their services and to contact the company about getting your risk-free trial period underway.

“We enjoy fewer formalities, less bureaucracy, and more freedom,” said Iyrna Ricker, a co-founder and software engineer at WeedHero. “This means we communicate in a more direct and personal way with you; we don’t sound like a corporate drone.”

You can also meet company representatives and learn more about WeedHero’s software offerings at the upcoming IndoExpo in Portland, Oregon on August 5-6. Stop by at Booth #130 to say hello, see a demo in person, and learn how WeedHero can fit into and benefit your business model!

Alternatively, you can join co-founder Constantine Yaremtso for a 45-minute workshop, where you will learn how to adopt online ordering and delivery systems from the get-go. The webinar workshop will take place on Wednesday, August 9 at 1:00 PST — click here to register.

End

Photo of a young hemp plant with a peach-colored back drop behind it.

Federal Lawmakers Introduce Measure to Treat Hemp Like Traditional Agricultural Crop

7/31/2017

a word from our sponsors:

A bi-partisan bill has been introduced in Congress to exempt industrial hemp from the definition of marijuana in the Controlled Substances Act and allow the further commercialization of hemp crops. The Industrial Hemp Farming Act was introduced by Republican Congressmen from Kentucky James Comer and Thomas Massie, Virginia’s Bob Goodlatte, and Colorado Democrat Jared Polis.

“I am honored to sponsor the Industrial Hemp Farming Act because I know firsthand the economic viability of industrial hemp,” Rep. Comer, the former Kentucky Commissioner of Agriculture said in a press release. “Hemp has created new opportunities for family farmers and good paying jobs for American workers, especially in Kentucky.”

Rep. Goodlatte said that “outdated, well-intentioned” federal restrictions on hemp are responsible for the lack of commercialization and cultivation of hemp in the U.S. and removing those restrictions “will finally allow for responsible commercial production without fear of violating federal law.”

Rep. Massie said he was “optimistic” that the bill would get to the president’s desk.

“In 2014, for the first time in over half a century, hemp was grown and harvested in Kentucky under the pilot programs allowed by the Polis-Massie-Blumenauer amendment to the 2014 Farm Bill,” he said. “I look forward to working with Congressman Comer to build on that momentum to give our nation’s farmers and manufacturers more opportunities to compete and succeed in the global economy.”

Rep. Polis called hemp a “sustainable alternative to plastics and other environmentally harmful products,” noting that it “can be used in everything from construction materials to paper to lotions and even ice cream.”

“It’s past time that we eliminate absurd barriers and allow hemp farmers to get to work, create jobs, and grow this promising and historically important crop,” he said.

The measure would treat hemp like other traditional agricultural crops like corn and soybeans.

End

The Massachusetts Capitol Building in Boston, Massachusetts.

Massachusetts Gov. Signs Adult Use Cannabis Compromise Bill

7/31/2017

a word from our sponsors:

Massachusetts Gov. Charlie Baker on Friday signed legislation revising some aspects of the voter-approved taxed-and-regulated cannabis industry, putting the adult-use rollout on track for July 1, 2018, according to an Associated Press report. The lawmaker-approved measure raises combined local and state taxes on products in the recreational marketplace from 12 to 20 percent. Medical cannabis sales will remain untaxed.

Additionally, the bill signed by Baker – who still opposes the law – sets strict packaging and advertising limits and provides directives for municipalities that wish to ban industry operations. Baker also indicated that he would provide additional resources to regulators if they need them. So far, Baker has included $2 million in the state budget for the five-member Cannabis Control Commission; lawmakers have approved another $300,000 to fund the program’s implementation.

Under state rules, current licensed operators will have the first crack at supplying and dispensing products under the adult use regime. Currently, there are 99 registered medical cannabis facilities and five farms. All interested individuals and businesses can begin applying in April, but current operators will be able to go through an expedited review process because they have already been vetted by the Health Department, the Boston Herald reports.

Sen. Patricia Jehlen said the expedited process will ensure “there’s going to be enough supply to serve the retail markets” as officials are hoping to avoid running low on product as was the case when Nevada began legal sales earlier this month.

The state Department of Revenue estimates legal cannabis sales could be worth $64 million in state revenues during their first year.

End

The Maryland Capitol Building in Annapolis. MD.

Some Maryland MMJ Application Reviewers Had Ties to Applicants

7/31/2017

a word from our sponsors:

The Maryland Medical Cannabis Commission is investigating potential conflicts of interest by those who reviewed the state’s medical cannabis applications after an investigation by the Washington Post discovered several of the “independent experts” had ties to companies whose applications they reviewed.

The applications were reviewed by Towson University’s Regional Economics Studies Institute, who oversaw 20 experts scoring the applications. However, the state Department of Legislative audits criticized the commission for using the institute because they, after an audit, concluded that the deal between the university and the MMCC circumvented “competitive procurement” standards resulting “in a lack of assurance that these services were obtained at the most advantageous cost to the State.”

According to the Post review, Julia Germaine, co-founder of Massachusetts’ Temescal Wellness, was among those reviewing applications and on an affidavit indicated she has “no known relationships” with individuals applying for a cannabis license; however it was later discovered she reviewed the application for Temescal, submitted by Ted Rebholz, a director and consultant, and her husband Nial DeMena, the co-founder of her Massachusetts company. Two heads of a Washington D.C. dispensary were also present on the panel and their business partners were among those seeking to expand into the state market – one disclosed the relationship, the other did not. Germaine claims she didn’t know her husband was a part of the Temescal application, and her husband claims he didn’t know she was an evaluator.

Daraius Irani, director of the RESI said the institute “took every step to ensure a fair process,” adding that while “it is not a conflict of interest simply to know someone professionally” working in the industry, Germaine “would have not have been an evaluator at all” if she had disclosed her husband was the general manager and she was affiliated with a potential licensee.

Patrick Jameson, the executive director of the MMCC, said the body “takes its role concerning the integrity of [the program] and fair application process very seriously and has been closely monitoring any and all situations of non-compliance to ensure the public trust.”

“The Commissioners will evaluate all available background investigation information prior to their deliberative process before issuing any licenses,” he said.

End

A grey-scale image of an indoor medical cannabis plant in California.

Canopy Boulder Startup Incubator Announces Fall Class

7/31/2017

a word from our sponsors:

Canopy Boulder has accepted eight startups for its Fall 2017 class, including a cloud-based quality management tool for multi-state canna-business operators, an agriculture technology hardware service, and a software platform that helps businesses manage and mine their online reviews. Each startup accepted to the program receives $30,000 in seed funding with the opportunity to earn another $50,000 later.

Patrick Rea, co-founder and managing director of Canopy, said the state’s industry has “shifted from just keeping up with demand to competing and stealing market share from one another” which has led to “increased interest in, and demand for, the cannabis technology companies that Canopy is investing in.”

“We expect this trend to continue nationwide as state markets mature,” he said in a press release.

The companies accepted to the Fall program include:

Colorado-based Virtugro, who develops automated grow-tech solutions for medium to large-scale cultivators.

My THC Guide, founded by Ebony Costain of Appamattox, Virginia, and Jameson Bennett of Louisville, Kentucky, a chatbot for the cannabis industry.

Cannabis Quality Group, developers of the cloud-based integrated quality management system.

Serene, founded by Ed Mcllory and Adam Bray of London, England, which encourages an outdoor, active lifestyle by leveraging technology.

Redfield Proctor, a “startup in stealth mode” focused on cannabis industry efficiency.

Dispenserly, which manages, monitors, and mines cannabis industry reviews to identify new opportunities and trends.

DeepGreen, which uses artificial intelligence and machine vision technology to identify plant characteristics. The company is founded by an international team hailing from Germany and France.

GreenScreens manages a network of digital flat screens in dispensaries throughout the country that rotate menu information and advertising to inform and target customers in the store.

In addition to funding, companies are able to work with experienced industry mentors and have access to Canopy partner services.

End

The U.S. Capitol Building in Washington D.C.

Senate Appropriations Committee Approves Amendment Preventing MMJ Crackdown

7/28/2017

a word from our sponsors:

The Senate Appropriations Committee has approved the Rohrbacher-Blumenauer amendment, which protects state-approved medical cannabis programs from federal interference, as part of the 2018 Commerce, Justice and Science appropriations bill, according to a report from the Hill. Specifically, the amendment prevents the Department of Justice from using federal funds to crack down on state-legal medical cannabis programs.

The vote rebukes a request from Attorney General Jeff Sessions, who sent a letter to members of Congress last month urging them to oppose the measure.

Aaron Smith, executive director of the National Cannabis Industry Association, said it was “great to see” the committee members approve the amendment and that “now it’s time for the House to do the same.”

“Patients deserve access to care, states deserve respect, and members of the House deserve the opportunity to vote on amendments like this that have the strong support of their constituents,” Smith said in a statement, adding that “more than 90 percent of Americans favor medical marijuana policies.”

The amendment was offered by Vermont Sen. Patrick Leahy, a Democrat, who argued the Justice Department has more important things to do “than tracking down doctors or epileptics using medical marijuana in their state.”

“The federal government can’t investigate everything and shouldn’t, and I don’t want them pursuing medical marijuana patients who are following state law,” he said in the report.

On Tuesday, House Republicans blocked budget amendments that would have allowed veterans to access state-legal medical cannabis programs and provided hemp producers access to federally-controlled water.

The House appropriations committee approved the amendment last month, and Rep. Dana Rohrabacher indicated he would offer the amendment to the House Commerce, Justice and Science Appropriations bill.

End

City Hall building in Los Angeles, California.

Cannabis Business Regulations Introduced in Los Angeles

7/28/2017

a word from our sponsors: